2μg (R: reducing condition, N: non-reducing condition).
GMF-β Protein, Human
GMF-β Protein, Human
Price:
Regular price
$65 USD
Regular price
Sale price
$65 USD
Unit price
per
For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details
Product Details
Product Details
Product Specification
| Species | Human |
| Synonyms | Glia maturation factor beta, GMF-beta |
| Accession | P60983 |
| Amino Acid Sequence | Ser2-His142 |
| Expression System | E.coli |
| Molecular Weight | 16 kDa (Reducing) |
| Purity | >95% by SDS-PAGE and HPLC |
| Endotoxin | <0.1EU/μg |
| Conjugation | Unconjugated |
| Tag | No Tag |
| Physical Appearance | Lyophilized powder |
| Storage Buffer | PBS, pH7.4 |
| Reconstitution | Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation. |
| Stability & Storage | ·12 months from date of receipt, lyophilized powder stored at -20 to -80℃. |
| Reference | Trends Cell Biol. 2018 Sep;28(9):749-760. |
Background
Glia Maturation Factor beta (GMFB) is a 17 kDa intracellular protein primarily expressed in the brain's glial cells, though it is also present in other tissues. As a member of the actin-depolymerizing factor family, it functions as a crucial intracellular regulator of actin cytoskeleton dynamics and cellular signaling pathways (notably enhancing p38 MAPK and inhibiting ERK). Its dysregulation is a key amplifier of inflammatory responses and oxidative stress, linking it to the pathology of numerous diseases.
GMFB is a major driver in diseases like Alzheimer's, Parkinson's, and Multiple Sclerosis, where it promotes glial activation and cytokine release. It is considered a promising therapeutic target; studies show GMFB deficiency protects against neuroinflammation.
Picture
Picture
SDS-PAGE
RP-HPLC
>95% as determined by RP-HPLC.
